"At Burjeel Medical City, we take pride in treating patients and their families with compassion and kindness, while working to achieve the best possible outcome for each patient."

During the past decade, Burjeel Medical City conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Burjeel Medical City" are "Non-Transfusion-dependent Alpha-Thalassemia" (1 trials), "Non-Transfusion-dependent Beta-Thalassemia" (1 trials), "Transfusion-dependent Alpha-Thalassemia" (1 trials) and "Transfusion-dependent Beta-Thalassemia" (1 trials). Many other conditions were trialed in "Burjeel Medical City" in a lesser frequency.

Most popular intervention types in "Burjeel Medical City" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mitapivat" (2 trials) and "Placebo Matching Mitapivat" (2 trials). Other intervention names were less common.

The vast majority of trials in "Burjeel Medical City" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Burjeel Medical City". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Burjeel Medical City, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Burjeel Medical City, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".